Cite
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
MLA
Veluchamy, John Pradeep, et al. “Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.” PLoS ONE, vol. 11, no. 6, June 2016, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0157830.
APA
Veluchamy, J. P., Spanholtz, J., Tordoir, M., Thijssen, V. L., Heideman, D. A. M., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2016). Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. PLoS ONE, 11(6), 1–16. https://doi.org/10.1371/journal.pone.0157830
Chicago
Veluchamy, John Pradeep, Jan Spanholtz, Marleen Tordoir, Victor L. Thijssen, Daniëlle A. M. Heideman, Henk M. W. Verheul, Tanja D. de Gruijl, and Hans J. van der Vliet. 2016. “Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.” PLoS ONE 11 (6): 1–16. doi:10.1371/journal.pone.0157830.